Review: Peripheral motor neuropathy in Cladribine
This is a review of Peripheral motor neuropathy by studying 637 people who take Cladribine. We analyze: the time on Cladribine when people have Peripheral motor neuropathy, gender and age of these people, the severity of Peripheral motor neuropathy, how they recovered, and common conditions and drugs used besides Cladribine. The review is created by eHealthMe based on reports from FDA and social media, and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 200 million drug outcomes from FDA and social media since 1977. The results are personalized to your gender and age. Start now >>>
Cladribine (latest outcomes) has active ingredients of cladribine. Commonly reported side effects of Cladribine include fever, pancytopenia, agranulocytosis, myelodysplastic syndrome, sepsis.
Peripheral motor neuropathy
Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years) has been reported by people with breast cancer, lung cancer - non-small cell, pain, high blood pressure, colon cancer.
On Nov, 27, 2013: 637 people reported to have side effects when taking Cladribine. Among them, 3 people (0.47%) have Peripheral Motor Neuropathy.
Time on Cladribine when people have Peripheral motor neuropathy * :
Gender of people who have Peripheral motor neuropathy when taking Cladribine * :
|Peripheral motor neuropathy||0.00%||100.00% |
Age of people who have Peripheral motor neuropathy when taking Cladribine * :
|Peripheral motor neuropathy||0.00%||0.00%||0.00%||0.00%||0.00%||100.00%||0.00%||0.00% |
Severity of Peripheral motor neuropathy when taking Cladribine ** :
How people recovered from Peripheral motor neuropathy ** :
Top conditions involved for these people * :
- Chemotherapy (3 people, 100.00%)
- Product used for unknown indication (1 people, 33.33%)
- Acute lymphocytic leukaemia (1 people, 33.33%)
Top co-used drugs for these people * :
- Methotrexate (3 people, 100.00%)
- Cytarabine (3 people, 100.00%)
- Dexamethasone (3 people, 100.00%)
- Atriance (3 people, 100.00%)
- Ifosfamide (3 people, 100.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related search: Cladribine, Peripheral motor neuropathy
You can also:
Browse Cladribine side effects from A to Z:
Browse Cladribine drug interactions with drugs from A to Z:
Drugs in real world that are associated with:
Could your condition cause it?
Can you answer these questions (what is this?):
More questions for: Cladribine, Peripheral motor neuropathy
More reviews for: Cladribine, Peripheral motor neuropathy
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.